Clinical Trial: Dose Reduction and Discontinuation With Anti-Fibrotic Medications

Study Status: COMPLETED
Recruit Status: COMPLETED
Study Type: OBSERVATIONAL




Official Title: Assessment of the Dose Reduction and Discontinuation Associated With Anti-Fibrotic Medications in Patients With Idiopathic Pulmonary Fibrosis

Brief Summary: The overarching aim of our study is to assess the incidence of dose reduction and discontinuations for pirfenidone and nintedanib.